Рет қаралды 128
Over the past decade, revolutionary technologies have led to an unprecedented explosion of disease data. This panel explores how we can ensure providers have the resources to distill, use, and champion these complex data and diagnostic solutions in their quest for precision patient care.
Moderated by Ephraim Tsalik, MD, PhD
Panelists:
Scott L. Friedman, MD, Icahn School of Medicine at Mount Sinai
Mara Aspinall, MBA, BlueStone Venture Partners
Kemi Badaki-Makun, MD, PhD, Johns Hopkins School of Medicine
Lincoln Nadauld, MD, PhD, Culmination Bio, Intermountain Precision Genomics